Oura agrees to buy AI primary care company Counsel Health for $625 million
Smart ring maker Oura will pay $625 million in cash for Counsel Health, MedTech Dive reported. Counsel is a physician-supervised AI care platform Oura has partnered with since May, and Oura plans to offer the service inside the Oura app.

- Value
- $625M
- Type
- Acquisition
- Target
- Counsel Health
- Buyer
- Oura
- Sector
- Health AI
- Announced
- Nov. 10, 2026
Oura built its business on measuring how people sleep, move and recover. Now it is buying a company whose doctors can diagnose and treat them.
The smart ring maker said Nov. 10 that it has agreed to acquire Counsel Health, a physician-supervised artificial intelligence care platform. Oura is paying $625 million in cash, MedTech Dive reported, subject to purchase price adjustments and customary closing conditions. Oura expects the deal to close near the end of this year.
Why it matters: The deal moves Oura from consumer health tracking toward delivering clinical care, and it puts a price on AI-first primary care that keeps a doctor in the loop. Counsel had raised $36 million in total, including a $25 million Series A in 2025 led by Andreessen Horowitz and GV, Digital Health News reported.
The two companies are not strangers. They have partnered since May, and Oura members can already try Counsel through the company's Oura Labs program. Oura said more than half of the Counsel users in Oura Labs have shared their ring data with their physicians since the partnership began.
How Counsel works
Oura describes Counsel's service as AI-native and supervised by board-certified physicians. A user starts by messaging Counsel's AI about a health question, a symptom or a lab result. Behind the scenes, AI agents take a medical history, review records, pull clinical guidelines and watch for emergencies, MedTech Dive reported. When a user wants a person, a Counsel physician can join the conversation and, according to Oura, diagnose, treat, order labs and prescribe when appropriate.
Inside the Oura app, those physicians could see a member's ring data and past conversations, if the member grants permission. Counsel will also keep working with health plans and health systems, including for people who never wear an Oura Ring, Oura said.
Tom Hale, Oura's chief executive, framed the deal around access. "Getting care is increasingly difficult due to a confluence of higher healthcare costs, a shortage of doctors, and limited time allotted to live doctor-patient visits," he said.
Muthu Alagappan, Counsel's founder and chief executive, made the case for the data. "Continuous health context makes medical AI more useful and relevant to each person," he said.
What comes next
The acquisition comes weeks after Oura put its own public debut on hold. The company sought to raise up to $2.2 billion in an initial public offering in September, then delayed the IPO later that month, citing market uncertainty, MedTech Dive reported. Oura has also been adding health features and partnering with medtech companies such as Resmed and Dexcom, the outlet noted.



